The presentation videos and slides for speakers’ lectures are made available, provided that they have granted us permission to do so.
COVID-19 Clinical Forum 2022
Related Enduring Materials
Enduring Materials
Tuesday, 13 December -
Update on COVID-19 Therapeutics
Update on Prevention and Treatment of COVID-19 in Immunocompromised Populations
Vaccine Responses in People Living with HIV
Tuesday, 20 September -
Kathryn Stephenson, MD, MPH
Update on COVID-19 Therapeutics
COVID-19 Vaccine Boosters - Where Are We Now?
Harvard Medical School / Ragon Institute / Beth Israel Deaconess Medical Center, United States
Long COVID - What Have We Learned So Far?
Tuesday, 17 May -
Jacob E. Lemieux, MD, DPhil
Update on COVID-19 Therapeutics
Vaccines, Variants and the Risk of Long COVID
SARS-CoV-2 Evolution: Where Do We Go From Here?
Harvard Medical School, Massachusetts General Hospital, The Broad Institute of MIT and Harvard, United States
Tuesday, 1 March -
Anna Maria Geretti, MD, PhD, FRCPath
Update on COVID-19 Therapeutics
Vaccine Effectiveness Against the Omicron Variant
University of Rome, Italy / King's College London, United Kingdom
Does Omicron Signal the End of the Pandemic?
Overview
Image
About this Program
The COVID-19 Clinical Forum 2022 was a series of 4 online interactive meetings (90 minutes each) that provided continuing education to a wide range of healthcare professionals, including infectious disease doctors, pulmonologists, and virologists, among others. The program encompassed a broad range of topics, from COVID-19 epidemiology, treatments, post-COVID conditions & clinical manifestations, clinical management, pathophysiology, prevention, vaccines, diagnostics, and public health strategies.
This EACCMED-accredited program was continuously updated as new information emerges and provides the latest COVID-19 data from renowned experts to clinicians worldwide. This program was designed to provide state-of-the-art, concise and comprehensive lectures, and to facilitate participation from healthcare professionals from around the world.
Program Directors
General Information
Topics of Interest
The program encompassed a wide range of topics, from vaccine research, immune response, SARS CoV-2 infection, diagnostics, and the use of artificial intelligence to contain the spread of the virus, to clinically orientated lectures on the emerging treatment options and novel insights into disease pathophysiology.
The series included continuous updates on COVID-19 infection control, epidemiology, prevention, diagnosis, pathogenesis, pathophysiology, clinical manifestations and management, emerging variants, therapeutic options, vaccine development and Implementation, public health measures, and treatments.
The series included continuous updates on COVID-19 infection control, epidemiology, prevention, diagnosis, pathogenesis, pathophysiology, clinical manifestations and management, emerging variants, therapeutic options, vaccine development and Implementation, public health measures, and treatments.
Who Should Attend?
-Healthcare providers involved in the care of SARS-CoV2 infected patients;
-Infectious disease clinicians;
-Clinical virologists;
-Primary care physicians;
-Intensivists;
-Microbiologists; and
-Specialized nurses.
-Infectious disease clinicians;
-Clinical virologists;
-Primary care physicians;
-Intensivists;
-Microbiologists; and
-Specialized nurses.
Practical Information
We trust that the following information will assist you in organizing your participation for the COVID-19 Clinical Forum 2022 webinar series.
Certificate of Attendance
A digital certificate of attendance will be sent to participants that have successfully completed the program and post-meeting survey.
Language
The official language of the webinar is English. Translation will not be provided.
Liability and Insurance
By registering for the webinar, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Support
MSD has provided partial funding for this Independent Medical Education program.
MSD has had no input into the selection of speakers or the content of the materials and presentations.
The December Edition of COVID-19 Clinical Forum 2022 was supported by a grant from Pfizer Inc.
Support Our Initiative
In order to deliver this program and allow healthcare professionals to attend, we depend on financial support.
We would like to encourage you to show your commitment to knowledge sharing and education on this important topic, by supporting this program with an Independent Medical Education grant.
By supporting this program, you will help to improve patient care and contribute to the fight against COVID-19.
Your support will be greatly appreciated!
Please contact Ms. Federica Ressa at federica@amededu.com or call +31 30 230 7140.
Endorsers
The COVID-19 2022 series was endorsed by the following organizations:
Media
SARS-CoV-2 Variants and Their Potential Biological Implications
Lecture: SARS-CoV-2 Variants and Their Potential Biological Implications
Speaker: Vineet Menachery, PhD
University of Texas Medical Branch, United States
Presented at: COVID-19 Clinical Forum 2021 – January Edition
The COVID-19 Clinical Forum is a series of online interactive meetings. This program will be frequently updated as new data emerges.
The duration of each online (live) event is approximately 90 minutes. Registration fee for the webinars is waived for healthcare professionals. Follow our interactive livestream and get the most up-to-date information from international experts.
For more medical education programs, as well as the latest scientific information, visit https://academicmedicaleducation.com/
COVID-19 Vaccine Safety: Short- and Long- Term
Lecture: COVID-19 Vaccine Safety: Short- and Long- Term
Speaker: Karine Lacombe, MD, PhD
Hôpital Saint Antoine Paris, France
Presented at: COVID-19 Clinical Forum 2021 – April Edition
The COVID-19 Clinical Forum is a series of online interactive meetings. This program will be frequently updated as new data emerges.
The duration of each online (live) event is approximately 90 minutes. Registration fee for the webinars is waived for healthcare professionals. Follow our interactive livestream and get the most up-to-date information from international experts.
For more medical education programs, as well as the latest scientific information, visit https://academicmedicaleducation.com/
Language
Related Programs
